Related Experiment Video
Updated: Jul 30, 2025

06:33
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.3K
Research progress on the hematopoietic microenvironment in aplastic anemia.
Hangchao Li1, Chenjie Zhou2, Yingying Shen1
1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
European Journal of Haematology
|May 19, 2023
Summary
Aplastic anemia involves bone marrow failure causing pancytopenia. Recent research focuses on the hematopoietic microenvironment, offering new insights for treating this complex disease.
Area of Science:
- Hematology
- Bone Marrow Biology
- Immunology
Background:
- Aplastic anemia (AA) is characterized by bone marrow hematopoietic failure and pancytopenia.
- The exact pathogenesis of AA remains largely unknown.
- Research has primarily focused on immune abnormalities, with less attention paid to the hematopoietic microenvironment.
Purpose of the Study:
- To summarize recent advancements in understanding the hematopoietic microenvironment in aplastic anemia.
- To explore novel therapeutic strategies for AA based on microenvironmental research.
Main Methods:
- Literature review of recent studies on the hematopoietic microenvironment in AA.
- Analysis of research focusing on cellular and molecular aspects of the bone marrow niche.
Main Results:
- Recent studies reveal significant alterations in the hematopoietic microenvironment of AA patients.
- Specific cellular and molecular changes within the niche contribute to hematopoietic failure.
- Understanding these microenvironmental factors is crucial for disease progression.
Conclusions:
- The hematopoietic microenvironment plays a critical role in the pathogenesis of aplastic anemia.
- Targeting the bone marrow microenvironment presents promising avenues for novel AA therapies.
- Further research into the AA hematopoietic niche is warranted for improved clinical outcomes.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Overview of Hematopoiesis
4.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.2K
Erythropoiesis
4.4K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.4K

